Alumni

Alumni
QuickFire
Challenge Winner
Developing next-generation surgical adhesives based on polyurethane, which permit quick
Alumni
Bridge Biotherapeutics’ mission is to develop therapeutics forthe effective treatment of
Alumni
Cardiovate is developing a significant change to the repair and replacement of diseased
Alumni
The Cell Culture Engineering Lab of the Federal University of Rio de Janeiro, suported by
Alumni
EvaHeart’s mission is to return severe heart failure patients to their home with high
Alumni
IGXBio is developing advanced DNA immunotherapies for diseases- our lead program, GenePro,
Alumni
Design and manufacturing of proprietary technology and processes making it possible to
Alumni
A real-time, HIPAA-compliant solution that gives health eco-system partners (hospitals,
Alumni
Kode Biotech USA is the US subsidiary of Kode Biotech, based in Auckland, New Zealand. We
Alumni
A clinical-stage immunotherapy company dedicated to the development of highly selective
Alumni
Metaclipse Therapeutics Corporation (“Metaclipse” or the “Company”) is a preclinical-stage
Alumni
Commercializing revolutionary silicon-based medical nanotechnology products that address
Alumni
Patient monitoring system to accurately and non-invasively measure cerebral venous
Alumni
For pharmaceutical and biotech companies that develop treatments for infectious disease
Alumni
QuickFire
Challenge Winner
Procyrion is a team of experienced life science entrepreneurs, engineers, cardiologists,